Skip to content
Search AI Powered

Latest Stories

High Times Tumultuous IPO Shelved Yet Again

The Dean of Cannabis Businesses Just Can't Seem to Get Their IPO Act Together
The Dean of Cannabis Businesses Just Can't Seem to Get Their IPO Act Together
Courtesy of The Bluntness Studios

Cannabis Law Report has confirmed that The Securities and Exchange Commission has informed High Times Holdings that they must halt accepting IPO investments because they failed to meet an extended deadline to file their audited annual report.  But, even with this warning, High Times has not refrained from pitching potential Cannabis investors via email solicitations, according to marketing material forwarded to Cannabis Law Report this week.

High Times securities lawyers, Stephen Weiss and Megan Penick of L.A. based Michelman Robinson LLP, who should have been aware of the Company's continued solicitations, confirmed that the High Times will not accept further sales until they get their annual report filed and publicly available for investors.


As of the date of this report, the High Times Investor solicitation portal is still active and functional.

Broken Promises: High Times Troubling IPO Path

The company has extended the offering of shares for two years, initially telling investors that it would list its shares on the NASDAQ. Then it lowered those expectations to the Over-The-Counter Marketplace. Still, neither of these promises has been fulfilled.

According to Debra Borchardt at Green Market Report, High Times continually announces acquisitions, enthusiastically telling investors how much money the new acquisition will bring in. Then months later, the deal typically quietly goes away - sometimes announced in an SEC filing and sometimes through a press release. In some cases, the acquisitions just never close and stay in a suspended state waiting for the shares to go public as payment for the acquisition.

A purchase of working cannabis dispensary stores and licenses in three U.S. states from publicly traded Harvest Health is the most recent example.  The original deal signed in April valued at $80 million included 13 dispensary licenses and then last month it was announced High Times would only be buying 10 licenses and they’d be losing two working California dispensaries in the renegotiated deal.

How Did High Times Become the Fyre Festival of Cannabis?

In 2017, the old-school pot magazine you remember as High Times looked to be blooming into a marijuana empire. That year, The New York Times initially reported that a group of wealthy Los Angeles-based investors, including Bob Marley’s son, Damian, acquired the magazine for $70 million, establishing a new parent company called High Times Holding Co.

However, the Times quickly issued a correction to that report, clarifying that “the group acquired a controlling stake that valued the magazine at $70 million; it did not pay $70 million.” All of this confusion should have been an omen of things to come.

High Times Once Earned 70% of Company Revenue from its Cannabis Cup EventsHigh Times Once Earned 70% of Company Revenue from its Cannabis Cup Events

High Times pivoted its core business to producing Cannabis Cup events, and they went on a spending spree to acquire and put their name on many of the world’s biggest marijuana festivals. These events once accounted for 70% of the Company's revenue, but High Times has not hosted an event since the 2019 Detroit Cannabis Cup.

Closer to home, just one year after acquiring Humboldt County’s popular Reggae on the River music festival, the event was cancelled — and some of their other California Cannabis Cup events failed to get permits or were cancelled last-minute.

High Times carried on with a grand plan for an IPO, hoping to list their shares on the NASDAQ and ride the green rush to riches. But the company couldn’t secure much interest from the traditional investor community, so instead they turned to a much smaller, cannabis-specific penny stock exchange called the OTCQX, and started a crowdfunding campaign aimed at their longtime readers and fans to launch a new mini-IPO. The have yet to raise the level of investment they have been seeking.

In May of 2020, their recently appointed CEO Stormy Simon resigned just after less than 4 months on the job. The company is now on its third CEO in less than a year, a dubious sign for investors and the dispensaries involved, considering this supposedly $80 million transaction is an almost all-stock deal. 

Their stock offering is particularly surreal, because High Times stock technically does not even exist. High Times sends potential investors three or four emails every day with messages like “Time is ticking, don’t miss out!”. The company has now extended its investor deadline at least seven times in the last 18 months.

All we can say is: Buyer Beware.

More For You

Jimi Hendrix - The Bluntness

The record Jimi Hendrix listened to on his first acid trip - The Bluntness

Jimi's legendary first trip

Picture the scene: it’s January 3rd 1966, in New York City, and a young Jimi Hendrix has just sent his father in Seattle an Empire State Building postcard admitting that the grass is not in fact greener on the other side and “every thing so-so on this big, raggedy city”. Although he doesn’t know it yet, Hendrix’s life is about to change seismically with the introduction of LSD.

Having spent four years residing in the Big Apple as a permanently broke musician, Hendrix had experienced his fair share of Black juke joints and clubs around the continent. Despite the gruelling nature of the ‘chitlin circuit’, comprising venues in the eastern, southern, and upper Midwest areas of the United States, Hendrix honed his craft by borrowing crowd-pleasing techniques from T-Bone Walker and Buddy Guy. A couple of these antics included the signature Hendrix trick of playing guitar behind his head and with his teeth.

Keep ReadingShow less
Indica vs. Sativa: Are These Cannabis Labels Outdated? - The Bluntness

Indica vs. Sativa: Are These Cannabis Labels Outdated? - The Bluntness

Indica vs Sativa: The Truth

When you walk into a dispensary, the first question you’re often asked is whether you prefer an “indica” or “sativa” strain. For years, these categories have served as shorthand for cannabis effects: sativas are described as energizing and creative, while indicas are thought to promote relaxation and sleep. But as cannabis science evolves, so does the understanding of what truly influences a cannabis experience—and it turns out that the traditional indica/sativa dichotomy might be more marketing myth than scientific fact.

This article dives into the origins of these terms, the science debunking their validity, and why a new classification system could lead to a better consumer experience.

Keep ReadingShow less
How to Get Free Weed - The Bluntness

How to Get Free Weed - The Bluntness

Free Weed: Easy Tips!

An increase in legalized weed is great – until you start getting hit with higher prices. If you’re a dedicated cannabis consumer, one of the most important things for you to know is how to get free weed.

Changes in the law have facilitated the distribution of free cannabis in legal states, making it easier for organizations to provide free medical cannabis to patients.

Keep ReadingShow less
If you need cannabis to get you through the day, career choice matters.
If you need cannabis to get you through the day, career choice matters.
Image by Elf-Moondance from Pixabay

11 Career Paths for Cannabis Lovers Who Hate Drug Tests

The thing about cannabis legalization is this: a lot of employers are still drug testing. If you prefer to have cannabis in your life, it’s best to find work that supports your desires. 

Below are 11 different career paths where cannabis shouldn’t be an issue as long as it doesn’t negatively affect your performance.

Keep ReadingShow less
Trop Cherry Strain Review - The Bluntness

Trop Cherry Strain Review - The Bluntness

Balanced Hybrid: Trop Cherry


The Trop Cherry cannabis strain is a slightly Sativa-dominant hybrid (60% Sativa, 40% Indica), created from Tropicana Cookies and Cherry Cookies F3. This strain is known for its THC levels, which range from 16% to 24%, offering a blend of cerebral stimulation and body relaxation. Its terpene profile features beta-caryophyllene, limonene, linalool, humulene, and beta-pinene, giving it a unique flavor that combines sweet citrus, ripe cherries, and earthy undertones.

Keep ReadingShow less